论文部分内容阅读
The first generation direct antiviral agents （DAAs）highlighted substantial prognosis improvement amongliver transplant （LT） candidates and recipients withrecurrent hepatitis C virus （HCV） infection. During2014, second generation DAAs are associated withhi